Search results
Moderna Stock Takes Minimal Hit After New COVID Vaccine Topped Projected Estimates
Black Enterprise· 2 hours agoModerna announced an increase in stock price after their COVID vaccine exceeded sales estimates for...
Moderna plants new solid tumor trials for cancer vaccine, weeds PD-1 work after review
FierceBiotech· 23 hours agoMuch of Moderna’s focus is on nabbing FDA approval for a respiratory syncytial virus vaccine, a...
Moderna Focused on Cutting Costs, RSV Vaccine
Bloomberg· 24 hours agoModerna Chief Executive Officer Stéphane Bancel talks about how the biotech giant is cutting costs and developing new vaccines. The drugmaker expects to...
Moderna Reports Smaller Than Expected Q1 Loss, Prepares For RSV Vaccine And Spikevax 2024-2025...
Benzinga via Yahoo Finance· 19 hours agoThursday, Moderna Inc (NASDAQ:MRNA) reported a first-quarter EPS loss of $(3.07), down from an...
Moderna loses less than expected as Covid vaccine sales beat estimates, cost cuts take hold
CNBC· 1 day agoModerna on Thursday posted a narrower-than-expected loss for the first quarter as the company's...
Moderna reports $1.2bn net loss in Q1 2024
Pharmaceutical Technology via Yahoo Finance· 5 hours agoNet product sales plummeted by 91% compared to Q1 2023. This downturn aligns with the expected transition to a seasonal market for Covid-19 vaccines....
Moderna’s sales from its only product, the COVID-19 vaccine, fell 91% from last year
Fortune via Yahoo Finance· 17 hours agoModerna’s next focus is to continue rolling out mRNA vaccines, which teaches cells how to make the...
mRNA Is Promising A Breakthrough In Fighting Cancer
Benzinga via AOL· 4 days agoBy the looks of it, this was only the beginning of the healthcare revolution that mRNA triggered. Mainz Biomed N.V. (NASDAQ: MYNZ) to revolutionize...
Moderna COVID vaccine sales plummet 91 percent - The Boston Globe
The Boston Globe· 23 hours agoSales of Moderna’s COVID-19 vaccine plunged 91 percent from the previous year for the first quarter...
Moderna Puts Up Big Quarterly Beat; Could Shares Break Out?
Investor's Business Daily· 1 day agoModerna (MRNA) beat Wall Street's first-quarter expectations Thursday. The Covid vaccine maker came...
